Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients Source: Eur Respir J 2006; 27: 1229-1235 Year: 2006
Effect of continuous positive airway pressure on blood pressure and metabolic profile in women with sleep apnoea Source: Eur Respir J, 50 (2) 1700257; 10.1183/13993003.00257-2017 Year: 2017
Obstructive sleep apnea syndrome and left ventricular diastolic function: effects of nasal continuous positive airway pressure (CPAP) Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006
Decrease in blood pressure during continuous positive airway pressure treatment for obstructive sleep apnoea: still searching for predictive factors Source: Eur Respir J, 54 (1) 1901219; 10.1183/13993003.01219-2019 Year: 2019
The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Effect of automatic positive airway pressure (APAP) therapy on blood pressure (BP) in patients with obstructive sleep apnea (OSA) and hypertension Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008
Continuous positive airway pressure treatment in patients with OSA Source: Eur Respir Mon 2010; 50: 244-266 Year: 2010
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007
Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP Source: Eur Respir J 2006; 27: 128-135 Year: 2006
Factors influencing the level of efficient pressure of continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea (OSAS) Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea Year: 2016
The influence of continuous positive airway pressure (CPAP) on response to incremental exercise in sleep apnea patients Source: Eur Respir J 2004; 24: Suppl. 48, 567s Year: 2004
Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users Source: Eur Respir J 2006; 27: 761-766 Year: 2006
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005
Management of hypertension in obstructive sleep apnoea: predicting blood pressure reduction under continuous positive airway pressure Source: Eur Respir J, 50 (4) 1701822; 10.1183/13993003.01822-2017 Year: 2017
Role of positive airway pressure (CPAP/BOPAP) in patients with combined heart failure and sleep apnoea Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019
Socieconomic factors affecting the acceptance of continuous positive airway pressure in sleep apnoea syndrome patients Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
Positive effect of CPAP treatment on the control of difficult-to-treat hypertension Source: Eur Respir J 2007; 29: 951-957 Year: 2007
Impact of humidification on compliance and side effects in obstructive sleep apnea (OSA) patients under auto continuous positive airway pressure (ACPAP) therapy Source: Eur Respir J 2006; 28: Suppl. 50, 409s Year: 2006
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005